tradingkey.logo
tradingkey.logo
Search

Inovio Pharmaceuticals Inc

INO
Add to Watchlist
0.677USD
+0.021+3.20%
Close 07-31 16:00ETQuotes delayed by 15 min
61.49MMarket Cap
LossP/E TTM

INO Financials

See Inovio Pharmaceuticals Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Inovio Pharmaceuticals Inc Earnings Date

Latest Release
May 13, 2026
EPS / Forecast
-0.28/-0.35
Revenue / Forecast
0.00/250.00K
Period
FY2025 Earnings
Revenue(YoY)
65.34K
-69.99%
EPS(YoY)
-1.81
54.12%
Analyst Rating
BUY
2026/08/01
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
44.15%-0.28
109.39%0.06
2.48%-0.87
48.90%-0.61
61.01%-0.51
41.24%-0.65
41.00%-0.89
26.52%-1.19
30.69%-1.31
57.83%-1.10
---1.52
---1.61
---1.89
---2.61
----
----
----
----
----
----
Revenue
-100.00%0.00
-100.00%0.00
--0.00
-100.00%0.00
--65.34K
13.97%116.99K
-100.00%0.00
-55.41%100.76K
-100.00%0.00
-17.66%102.65K
-95.76%388.45K
-71.19%225.97K
-42.26%114.94K
-85.14%124.67K
3038.22%9.15M
187.51%784.39K
-46.36%199.07K
-84.96%839.12K
23.51%291.70K
2.11%272.82K
Net Profit
0.06%-19.68M
119.42%3.76M
-80.79%-45.50M
27.04%-23.52M
35.36%-19.69M
22.48%-19.38M
25.83%-25.17M
9.28%-32.24M
25.04%-30.47M
54.09%-25.00M
10.20%-33.93M
67.25%-35.53M
48.59%-40.65M
49.07%-54.46M
37.20%-37.78M
-32.09%-108.50M
-45.35%-79.07M
-339.42%-106.95M
-413.85%-60.17M
36.18%-82.14M
Net Margin
----
----
----
----
---30140.48%
31.99%-16566.39%
----
-103.45%-31993.31%
----
44.24%-24357.91%
---8734.77%
---15725.26%
---35364.76%
---43687.24%
----
----
----
----
----
----
Gross Margin
----
----
----
----
--100.00%
0.00%100.00%
----
0.00%100.00%
----
0.00%100.00%
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
----
----
----
Debt to assets ratio
----
----
----
----
----
-100.00%0.00%
-100.00%0.00%
-100.00%0.00%
-100.00%0.00%
93.37%9.81%
--8.54%
--7.17%
--6.15%
--5.07%
----
----
----
----
----
----
Revenue
-100.00%0.00
-100.00%0.00
--0.00
-100.00%0.00
--65.34K
13.97%116.99K
-100.00%0.00
-55.41%100.76K
-100.00%0.00
-17.66%102.65K
-95.76%388.45K
-71.19%225.97K
-42.26%114.94K
-85.14%124.67K
3038.22%9.15M
187.51%784.39K
-46.36%199.07K
-84.96%839.12K
23.51%291.70K
2.11%272.82K
Operating profit
12.38%-21.95M
14.20%-17.48M
22.44%-21.21M
30.46%-23.08M
19.89%-25.05M
25.64%-20.37M
-9.22%-27.35M
5.26%-33.20M
28.85%-31.27M
51.04%-27.39M
29.97%-25.04M
66.35%-35.04M
38.73%-43.95M
46.97%-55.95M
40.36%-35.76M
-25.16%-104.14M
-36.49%-71.73M
-259.61%-105.51M
-65.03%-59.95M
-150.75%-83.20M
Net Profit
0.06%-19.68M
119.42%3.76M
-80.79%-45.50M
27.04%-23.52M
35.36%-19.69M
22.48%-19.38M
25.83%-25.17M
9.28%-32.24M
25.04%-30.47M
54.09%-25.00M
10.20%-33.93M
67.25%-35.53M
48.59%-40.65M
49.07%-54.46M
37.20%-37.78M
-32.09%-108.50M
-45.35%-79.07M
-339.42%-106.95M
-413.85%-60.17M
36.18%-82.14M
Current assets
-45.14%39.44M
-37.52%61.12M
-39.55%55.18M
-55.17%52.70M
-35.63%71.89M
-36.11%97.83M
-47.77%91.28M
-42.17%117.56M
-52.25%111.68M
-51.43%153.11M
-50.10%174.77M
-51.16%203.28M
-41.51%233.90M
-29.70%315.24M
-28.15%350.21M
-23.27%416.19M
-32.04%399.91M
-4.82%448.44M
29.26%487.40M
41.97%542.42M
Total current liabilities
38.78%37.92M
23.62%43.67M
197.13%69.82M
20.11%31.71M
16.78%27.33M
-17.02%35.33M
-46.24%23.50M
-49.17%26.40M
-57.57%23.40M
-56.05%42.57M
-53.95%43.71M
-60.38%51.93M
-7.09%55.15M
47.35%96.87M
84.75%94.91M
153.27%131.06M
42.90%59.36M
57.63%65.74M
24.51%51.38M
36.25%51.75M
Total assets
-42.96%49.78M
-34.35%74.31M
-35.19%69.39M
-49.00%68.24M
-32.41%87.27M
-33.78%113.20M
-44.56%107.06M
-42.59%133.80M
-51.57%129.11M
-50.95%170.95M
-50.74%193.10M
-49.27%233.04M
-40.16%266.58M
-29.72%348.53M
-26.84%391.97M
-22.38%459.40M
-31.97%445.51M
-8.12%495.94M
22.37%535.76M
33.54%591.84M
Total liabilities
21.34%43.71M
12.35%50.21M
130.03%77.11M
7.16%39.71M
3.89%36.02M
-16.62%44.69M
-38.99%33.52M
-41.79%37.06M
-48.53%34.67M
-57.52%53.60M
-56.15%54.94M
-60.63%63.67M
-25.50%67.37M
31.06%126.17M
52.42%125.27M
94.18%161.73M
23.44%90.43M
22.43%96.27M
-27.79%82.19M
-67.57%83.29M
Total equity
-88.16%6.07M
-64.82%24.10M
-110.50%-7.72M
-70.51%28.53M
-45.73%51.25M
-41.62%68.50M
-46.77%73.54M
-42.88%96.74M
-52.59%94.44M
-47.23%117.35M
-48.20%138.16M
-43.10%169.37M
-43.90%199.21M
-44.36%222.36M
-41.20%266.70M
-41.47%297.67M
-38.95%355.09M
-13.33%399.67M
39.99%453.57M
172.89%508.55M
Net operating income
19.66%-21.59M
1.49%-19.37M
21.39%-21.57M
26.23%-20.81M
6.56%-26.87M
25.16%-19.66M
5.73%-27.44M
12.70%-28.21M
21.56%-28.76M
27.69%-26.28M
56.85%-29.11M
36.05%-32.31M
40.75%-36.66M
4.09%-36.34M
-45.12%-67.47M
35.60%-50.53M
-17.05%-61.88M
26.02%-37.89M
37.31%-46.49M
-188.97%-78.46M
Net investment
5193.15%2.64M
-100.17%-58.19K
-37.01%8.87M
-47.00%5.28M
-100.11%-51.75K
73.71%34.64M
356.25%14.08M
-81.51%9.97M
138.86%45.38M
-63.07%19.94M
-112.33%-5.49M
623.16%53.91M
-10.93%19.00M
931.55%54.00M
-20.38%44.56M
-120.48%-10.30M
107.75%21.33M
-74.75%-6.49M
43.06%55.96M
218.69%50.31M
Net financing
-7.21%953.79K
-6.90%27.13M
3672.40%24.92M
-100.11%-34.78K
109.05%1.03M
1485.47%29.15M
-5.44%660.65K
1045.85%33.03M
-2575.77%-11.36M
-72.43%1.84M
-81.67%698.63K
-93.29%2.88M
-101.49%-424.70K
-85.99%6.67M
964.73%3.81M
1147.71%42.94M
-82.34%28.42M
-62.51%47.59M
74.00%-440.78K
-97.28%3.44M

FAQs

What is the total revenue of Inovio Pharmaceuticals Inc?

According to Inovio Pharmaceuticals Inc's FY2025 earnings report, its total revenue reached 65.34K, with a year-on-year change of 217.76K.

What are the current assets of Inovio Pharmaceuticals Inc?

According to Inovio Pharmaceuticals Inc's FY2025 earnings report, its current assets were 61.12M, with a year-on-year change of -37.52.

What are the total assets of Inovio Pharmaceuticals Inc?

According to Inovio Pharmaceuticals Inc's FY2025 earnings report, its total assets of Inovio Pharmaceuticals Inc were 74.31M, with a year-on-year change of -34.35.

What are the total liabilities of Inovio Pharmaceuticals Inc?

According to Inovio Pharmaceuticals Inc's FY2025 earnings report, its total liabilities of Inovio Pharmaceuticals Inc were 50.21M, with a year-on-year change of 12.35.

What is the total equity of Inovio Pharmaceuticals Inc?

According to Inovio Pharmaceuticals Inc's FY2025 earnings report, its total equity of Inovio Pharmaceuticals Inc was 24.10M, with a year-on-year change of -64.82.

What is the net operating income of Inovio Pharmaceuticals Inc?

According to Inovio Pharmaceuticals Inc's FY2025 earnings report, its net operating income of Inovio Pharmaceuticals Inc was -86.82M, with a year-on-year change of 22.76.

What is the net investment of Inovio Pharmaceuticals Inc?

According to Inovio Pharmaceuticals Inc's FY2025 earnings report, its net investment of Inovio Pharmaceuticals Inc was 14.04M, with a year-on-year change of -86.51.

What is the net financing of Inovio Pharmaceuticals Inc?

According to Inovio Pharmaceuticals Inc's FY2025 earnings report, its net financing of Inovio Pharmaceuticals Inc was 53.05M, with a year-on-year change of 3.06.

What is the Earnings Per Share (EPS) of Inovio Pharmaceuticals Inc?

According to Inovio Pharmaceuticals Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -1.81, with a year-on-year change of 54.12.

What is the net income of Inovio Pharmaceuticals Inc?

According to Inovio Pharmaceuticals Inc's FY2025 earnings report, its net income was -84.95M, with a year-on-year change of 20.80.

What is the net margin of Inovio Pharmaceuticals Inc?

According to Inovio Pharmaceuticals Inc's FY2025 earnings report, its net profit margin was -130000.00, with a year-on-year change of -163.94.

What is the Return on Equity (ROE) of Inovio Pharmaceuticals Inc?

According to Inovio Pharmaceuticals Inc's FY2025 earnings report, its Return on Equity (ROE) was -183.47, with a year-on-year change of -58.96.

What is the Return on Assets (ROA) of Inovio Pharmaceuticals Inc?

According to Inovio Pharmaceuticals Inc's FY2025 earnings report, its Return on Assets (ROA) was -90.61, with a year-on-year change of -20.02.

What is the operating profit of Inovio Pharmaceuticals Inc?

According to Inovio Pharmaceuticals Inc's FY2025 earnings report, its operating profit was -86.82M, with a year-on-year change of 22.76.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.